

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.66828854 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.66828854 |
| 3 | positive regulation of vesicle fusion (GO:0031340) | 5.35566658 |
| 4 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 5.27387007 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.14053816 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.98678924 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.98678924 |
| 8 | L-fucose catabolic process (GO:0042355) | 4.72192175 |
| 9 | fucose catabolic process (GO:0019317) | 4.72192175 |
| 10 | L-fucose metabolic process (GO:0042354) | 4.72192175 |
| 11 | signal peptide processing (GO:0006465) | 4.71632631 |
| 12 | behavioral response to nicotine (GO:0035095) | 4.68030135 |
| 13 | endocrine pancreas development (GO:0031018) | 4.55609344 |
| 14 | peptide hormone processing (GO:0016486) | 4.47191752 |
| 15 | positive regulation of insulin secretion (GO:0032024) | 4.44347817 |
| 16 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.34964496 |
| 17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.29383318 |
| 18 | cellular ketone body metabolic process (GO:0046950) | 4.27877449 |
| 19 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.08090933 |
| 20 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.00189244 |
| 21 | response to dietary excess (GO:0002021) | 3.98551380 |
| 22 | ketone body metabolic process (GO:1902224) | 3.94368038 |
| 23 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.92638945 |
| 24 | protein retention in ER lumen (GO:0006621) | 3.92077967 |
| 25 | positive regulation of interleukin-12 production (GO:0032735) | 3.77859518 |
| 26 | positive regulation of type 2 immune response (GO:0002830) | 3.77038386 |
| 27 | DNA deamination (GO:0045006) | 3.76576185 |
| 28 | positive regulation of peptide hormone secretion (GO:0090277) | 3.73404241 |
| 29 | regulation of activation of Janus kinase activity (GO:0010533) | 3.73297494 |
| 30 | glandular epithelial cell differentiation (GO:0002067) | 3.71991759 |
| 31 | sequestering of metal ion (GO:0051238) | 3.69849175 |
| 32 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.67461987 |
| 33 | detection of light stimulus involved in visual perception (GO:0050908) | 3.67461987 |
| 34 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.66294486 |
| 35 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.63167025 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.58297019 |
| 37 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.57880605 |
| 38 | cellular response to vitamin D (GO:0071305) | 3.57165962 |
| 39 | indolalkylamine metabolic process (GO:0006586) | 3.55626708 |
| 40 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.55293741 |
| 41 | positive regulation of peptide secretion (GO:0002793) | 3.55250454 |
| 42 | regulation of hexokinase activity (GO:1903299) | 3.53701522 |
| 43 | regulation of glucokinase activity (GO:0033131) | 3.53701522 |
| 44 | kidney morphogenesis (GO:0060993) | 3.48417794 |
| 45 | tryptophan catabolic process (GO:0006569) | 3.48077439 |
| 46 | indole-containing compound catabolic process (GO:0042436) | 3.48077439 |
| 47 | indolalkylamine catabolic process (GO:0046218) | 3.48077439 |
| 48 | response to pheromone (GO:0019236) | 3.42421498 |
| 49 | COPII vesicle coating (GO:0048208) | 3.39271434 |
| 50 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.39105949 |
| 51 | piRNA metabolic process (GO:0034587) | 3.37999893 |
| 52 | growth hormone receptor signaling pathway (GO:0060396) | 3.37310732 |
| 53 | platelet dense granule organization (GO:0060155) | 3.36540906 |
| 54 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.35180759 |
| 55 | regulation of immunoglobulin secretion (GO:0051023) | 3.34866902 |
| 56 | neutrophil activation involved in immune response (GO:0002283) | 3.32335076 |
| 57 | axoneme assembly (GO:0035082) | 3.25868738 |
| 58 | eosinophil chemotaxis (GO:0048245) | 3.22285934 |
| 59 | type I interferon signaling pathway (GO:0060337) | 3.20620819 |
| 60 | cellular response to type I interferon (GO:0071357) | 3.20620819 |
| 61 | primary amino compound metabolic process (GO:1901160) | 3.19414236 |
| 62 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 3.18709829 |
| 63 | response to type I interferon (GO:0034340) | 3.17312689 |
| 64 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.15900012 |
| 65 | respiratory chain complex IV assembly (GO:0008535) | 3.14601807 |
| 66 | myeloid dendritic cell differentiation (GO:0043011) | 3.12905451 |
| 67 | regulation of RIG-I signaling pathway (GO:0039535) | 3.10489416 |
| 68 | T-helper 1 type immune response (GO:0042088) | 3.10285384 |
| 69 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.09964484 |
| 70 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.09789875 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05590761 |
| 72 | indole-containing compound metabolic process (GO:0042430) | 3.03963275 |
| 73 | tryptophan metabolic process (GO:0006568) | 3.03872496 |
| 74 | regulation of insulin secretion (GO:0050796) | 3.01077118 |
| 75 | regulation of action potential (GO:0098900) | 3.00189706 |
| 76 | positive regulation of hormone secretion (GO:0046887) | 2.99513698 |
| 77 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.96985111 |
| 78 | cellular response to vitamin (GO:0071295) | 2.96576987 |
| 79 | positive regulation of respiratory burst (GO:0060267) | 2.96537698 |
| 80 | response to lipoprotein particle (GO:0055094) | 2.96173755 |
| 81 | negative regulation of digestive system process (GO:0060457) | 2.95738541 |
| 82 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.95323295 |
| 83 | regulation of T cell tolerance induction (GO:0002664) | 2.93197031 |
| 84 | positive regulation of interferon-alpha production (GO:0032727) | 2.92355419 |
| 85 | glycerophospholipid catabolic process (GO:0046475) | 2.92282046 |
| 86 | adaptation of signaling pathway (GO:0023058) | 2.92249674 |
| 87 | serotonin metabolic process (GO:0042428) | 2.92060140 |
| 88 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.91384747 |
| 89 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.90280019 |
| 90 | epithelial cilium movement (GO:0003351) | 2.89890471 |
| 91 | toxin transport (GO:1901998) | 2.88934657 |
| 92 | negative regulation of JUN kinase activity (GO:0043508) | 2.86630012 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84432146 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 2.84233125 |
| 95 | positive regulation of amino acid transport (GO:0051957) | 2.84010049 |
| 96 | DNA methylation involved in gamete generation (GO:0043046) | 2.82915378 |
| 97 | cellular response to growth hormone stimulus (GO:0071378) | 2.82534976 |
| 98 | protein autoprocessing (GO:0016540) | 2.82445603 |
| 99 | protein localization to cilium (GO:0061512) | 2.81382171 |
| 100 | amyloid precursor protein catabolic process (GO:0042987) | 2.81067083 |
| 101 | synaptic transmission, cholinergic (GO:0007271) | 2.80065693 |
| 102 | toxin metabolic process (GO:0009404) | 2.79891624 |
| 103 | eosinophil migration (GO:0072677) | 2.77730657 |
| 104 | regulation of peptide hormone secretion (GO:0090276) | 2.77576106 |
| 105 | insulin secretion (GO:0030073) | 2.77107094 |
| 106 | negative regulation of mast cell activation (GO:0033004) | 2.76783013 |
| 107 | astrocyte differentiation (GO:0048708) | 2.76250687 |
| 108 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.76244257 |
| 109 | neuronal action potential (GO:0019228) | 2.76015986 |
| 110 | protein complex biogenesis (GO:0070271) | 2.74388909 |
| 111 | regulation of peptide secretion (GO:0002791) | 2.73947139 |
| 112 | glycine transport (GO:0015816) | 2.73699624 |
| 113 | regulation of memory T cell differentiation (GO:0043380) | 2.73479674 |
| 114 | negative regulation of interleukin-17 production (GO:0032700) | 2.73210010 |
| 115 | nitric oxide biosynthetic process (GO:0006809) | 2.72595531 |
| 116 | cytochrome complex assembly (GO:0017004) | 2.71004408 |
| 117 | nitric oxide mediated signal transduction (GO:0007263) | 2.69663989 |
| 118 | regulation of interferon-alpha production (GO:0032647) | 2.69337080 |
| 119 | neutrophil activation (GO:0042119) | 2.69279662 |
| 120 | peptide catabolic process (GO:0043171) | 2.69046292 |
| 121 | surfactant homeostasis (GO:0043129) | 2.68897034 |
| 122 | negative regulation of telomere maintenance (GO:0032205) | 2.68616197 |
| 123 | neuron fate specification (GO:0048665) | 2.67851326 |
| 124 | protein K11-linked deubiquitination (GO:0035871) | 2.67466376 |
| 125 | fucosylation (GO:0036065) | 2.66825685 |
| 126 | response to prostaglandin E (GO:0034695) | 2.66676289 |
| 127 | regulation of cholesterol storage (GO:0010885) | 2.65326779 |
| 128 | myeloid dendritic cell activation (GO:0001773) | 2.64776431 |
| 129 | reflex (GO:0060004) | 2.64371333 |
| 130 | neural tube formation (GO:0001841) | 2.62522677 |
| 131 | granulocyte activation (GO:0036230) | 2.62400353 |
| 132 | gamma-aminobutyric acid transport (GO:0015812) | 2.61940802 |
| 133 | negative regulation of multicellular organism growth (GO:0040015) | 2.61833381 |
| 134 | inositol phosphate catabolic process (GO:0071545) | 2.60612689 |
| 135 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.59591635 |
| 136 | regulation of interleukin-8 secretion (GO:2000482) | 2.59388988 |
| 137 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59301911 |
| 138 | positive regulation of glycolytic process (GO:0045821) | 2.59050073 |
| 139 | protein polyglutamylation (GO:0018095) | 2.58957921 |
| 140 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.58905675 |
| 141 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.58531004 |
| 142 | mannosylation (GO:0097502) | 2.57699331 |
| 143 | regulation of T-helper cell differentiation (GO:0045622) | 2.57379461 |
| 144 | vesicle coating (GO:0006901) | 2.56683190 |
| 145 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.56360249 |
| 146 | magnesium ion transport (GO:0015693) | 2.55714788 |
| 147 | retinal metabolic process (GO:0042574) | 2.54454453 |
| 148 | sexual reproduction (GO:0019953) | 2.53655397 |
| 149 | multicellular organism reproduction (GO:0032504) | 2.53410725 |
| 150 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.53298041 |
| 151 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52476766 |
| 152 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.52473711 |
| 153 | NADH dehydrogenase complex assembly (GO:0010257) | 2.52473711 |
| 154 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.52473711 |
| 155 | regulation of extracellular matrix disassembly (GO:0010715) | 2.50565141 |
| 156 | acrosome assembly (GO:0001675) | 2.50309230 |
| 157 | pharyngeal system development (GO:0060037) | 2.49378191 |
| 158 | auditory receptor cell stereocilium organization (GO:0060088) | 2.48888807 |
| 159 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.48832735 |
| 160 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.48376838 |
| 161 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.48254333 |
| 162 | peptide hormone secretion (GO:0030072) | 2.47856452 |
| 163 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.47117110 |
| 164 | regulation of hormone secretion (GO:0046883) | 2.47096523 |
| 165 | nucleobase catabolic process (GO:0046113) | 2.46619220 |
| 166 | retinal cone cell development (GO:0046549) | 2.45694350 |
| 167 | behavioral response to ethanol (GO:0048149) | 2.45236865 |
| 168 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.43737133 |
| 169 | polyol catabolic process (GO:0046174) | 2.43277460 |
| 170 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.43229435 |
| 171 | startle response (GO:0001964) | 2.40821056 |
| 172 | nonmotile primary cilium assembly (GO:0035058) | 2.40367534 |
| 173 | amine catabolic process (GO:0009310) | 2.40124877 |
| 174 | cellular biogenic amine catabolic process (GO:0042402) | 2.40124877 |
| 175 | sperm motility (GO:0030317) | 2.40075554 |
| 176 | photoreceptor cell maintenance (GO:0045494) | 2.39552059 |
| 177 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.38640786 |
| 178 | action potential (GO:0001508) | 2.38544492 |
| 179 | adenosine metabolic process (GO:0046085) | 2.38144684 |
| 180 | rhodopsin mediated signaling pathway (GO:0016056) | 2.37562297 |
| 181 | proline transport (GO:0015824) | 2.36213103 |
| 182 | benzene-containing compound metabolic process (GO:0042537) | 2.35978880 |
| 183 | cilium morphogenesis (GO:0060271) | 2.35464634 |
| 184 | negative regulation of protein oligomerization (GO:0032460) | 2.35421820 |
| 185 | dopamine transport (GO:0015872) | 2.34229886 |
| 186 | nephron epithelium morphogenesis (GO:0072088) | 2.33895248 |
| 187 | nephron tubule morphogenesis (GO:0072078) | 2.33895248 |
| 188 | positive regulation of meiosis (GO:0045836) | 2.32616860 |
| 189 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.31313642 |
| 190 | cilium movement (GO:0003341) | 2.31076164 |
| 191 | peristalsis (GO:0030432) | 2.29921794 |
| 192 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.29215331 |
| 193 | rRNA catabolic process (GO:0016075) | 2.29140780 |
| 194 | membrane repolarization during action potential (GO:0086011) | 2.27989594 |
| 195 | inositol phosphate dephosphorylation (GO:0046855) | 2.27631342 |
| 196 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.27631342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.15191409 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.28958113 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.82236198 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.68365576 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.66614829 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.62295438 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.43457231 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 3.24023976 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.23287455 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.00224447 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.80705457 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.76656814 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.70547229 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.57290611 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.54302487 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.48702355 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47863271 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.47472135 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.26156483 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.25042248 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.24342630 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.18218928 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16539934 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.15185268 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.15146020 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.08190211 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.04773657 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.03818552 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00381663 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94520185 |
| 31 | FUS_26573619_Chip-Seq_HEK293_Human | 1.94343469 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.92495788 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90496045 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87360893 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.86867127 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85454733 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85035240 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84442848 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.81255402 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78039634 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.77137783 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.75712531 |
| 43 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73675383 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73124012 |
| 45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.72927612 |
| 46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70908717 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70686215 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.68165784 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.66636715 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64594760 |
| 51 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63983740 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.60897175 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60713169 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60671367 |
| 55 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.59856802 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.57838920 |
| 57 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.56019337 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55687128 |
| 59 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.55519694 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.55519694 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55153688 |
| 62 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.53651697 |
| 63 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.52758767 |
| 64 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.51986280 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.51930761 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.49553503 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47550588 |
| 68 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45314398 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45129192 |
| 70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.43714826 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43681953 |
| 72 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.42795075 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.42511859 |
| 74 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.41537320 |
| 75 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.41537320 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41100522 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41015977 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40695725 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.39817866 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38795065 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38002743 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37429903 |
| 83 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.36559061 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34756922 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.34391826 |
| 86 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34354538 |
| 87 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33804142 |
| 88 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33804142 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32477831 |
| 90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.31964351 |
| 91 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30755552 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.30222454 |
| 93 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30222454 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.30011796 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29977963 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29703513 |
| 97 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29524757 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.28217676 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.27878486 |
| 100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.27229415 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26830173 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26830173 |
| 103 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26356610 |
| 104 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26308785 |
| 105 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26182826 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25370785 |
| 107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24791400 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24531109 |
| 109 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.24439077 |
| 110 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24320563 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23716485 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23572336 |
| 113 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.23540546 |
| 114 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23520817 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.23171209 |
| 116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23013352 |
| 117 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22941310 |
| 118 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.22614529 |
| 119 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22133733 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21615205 |
| 121 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19692396 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 1.19365208 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17806644 |
| 124 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16639276 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16180058 |
| 126 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15585145 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15460492 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14378788 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12794396 |
| 130 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12711490 |
| 131 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10976326 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10264807 |
| 133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10239286 |
| 134 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10222205 |
| 135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09890765 |
| 136 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09378523 |
| 137 | MYB_26560356_Chip-Seq_TH2_Human | 1.08711239 |
| 138 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.07957082 |
| 139 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07547722 |
| 140 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07141630 |
| 141 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06418364 |
| 142 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06134189 |
| 143 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05712428 |
| 144 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05568373 |
| 145 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05550340 |
| 146 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.04805283 |
| 147 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04680057 |
| 148 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04636422 |
| 149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04318499 |
| 150 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03516706 |
| 151 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02843046 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00723877 |
| 153 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.00194627 |
| 154 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00118299 |
| 155 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99409571 |
| 156 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99046296 |
| 157 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98882021 |
| 158 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97916619 |
| 159 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97807877 |
| 160 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97605232 |
| 161 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97522034 |
| 162 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97271416 |
| 163 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97247421 |
| 164 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.95735159 |
| 165 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.95607224 |
| 166 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94290658 |
| 167 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93008771 |
| 168 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92234183 |
| 169 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91842562 |
| 170 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.90693018 |
| 171 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90145131 |
| 172 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89637007 |
| 173 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89493621 |
| 174 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89306086 |
| 175 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88113526 |
| 176 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87916837 |
| 177 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87718892 |
| 178 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87427546 |
| 179 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83637963 |
| 180 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.82754510 |
| 181 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80845504 |
| 182 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.80845504 |
| 183 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.80258221 |
| 184 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76366939 |
| 185 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.75752696 |
| 186 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74263976 |
| 187 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74001691 |
| 188 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74001691 |
| 189 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.73992884 |
| 190 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.72793645 |
| 191 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70818978 |
| 192 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.70810022 |
| 193 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.70338286 |
| 194 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70238927 |
| 195 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69952572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 4.77007163 |
| 2 | MP0005379_endocrine/exocrine_gland_phen | 4.09593022 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 3.91981207 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.77521930 |
| 5 | MP0002163_abnormal_gland_morphology | 3.48194526 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.40081210 |
| 7 | MP0003195_calcinosis | 3.28485533 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.25729614 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.02212948 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.81915336 |
| 11 | MP0002693_abnormal_pancreas_physiology | 2.79024711 |
| 12 | MP0003787_abnormal_imprinting | 2.68060032 |
| 13 | MP0001944_abnormal_pancreas_morphology | 2.59521097 |
| 14 | MP0000003_abnormal_adipose_tissue | 2.58209924 |
| 15 | MP0010386_abnormal_urinary_bladder | 2.54757607 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.53452752 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.52383825 |
| 18 | MP0002102_abnormal_ear_morphology | 2.49059911 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.34780011 |
| 20 | MP0000678_abnormal_parathyroid_gland | 2.26840064 |
| 21 | MP0000685_abnormal_immune_system | 2.25733467 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.15113332 |
| 23 | MP0003724_increased_susceptibility_to | 2.12674721 |
| 24 | MP0005084_abnormal_gallbladder_morpholo | 2.08123314 |
| 25 | MP0004147_increased_porphyrin_level | 2.07719774 |
| 26 | MP0004782_abnormal_surfactant_physiolog | 2.03458037 |
| 27 | MP0003283_abnormal_digestive_organ | 2.02635398 |
| 28 | MP0001348_abnormal_lacrimal_gland | 2.00566454 |
| 29 | MP0001790_abnormal_immune_system | 1.96825209 |
| 30 | MP0005387_immune_system_phenotype | 1.96825209 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.94224985 |
| 32 | MP0009785_altered_susceptibility_to | 1.93299296 |
| 33 | MP0003878_abnormal_ear_physiology | 1.91596548 |
| 34 | MP0005377_hearing/vestibular/ear_phenot | 1.91596548 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.90269107 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.86822753 |
| 37 | MP0009745_abnormal_behavioral_response | 1.86144003 |
| 38 | MP0001968_abnormal_touch/_nociception | 1.85668214 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.84873976 |
| 40 | MP0008872_abnormal_physiological_respon | 1.84755413 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 1.82082513 |
| 42 | MP0005220_abnormal_exocrine_pancreas | 1.74048603 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.73523611 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.73383649 |
| 45 | MP0003011_delayed_dark_adaptation | 1.73331108 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.73316363 |
| 47 | MP0004885_abnormal_endolymph | 1.72083998 |
| 48 | MP0009046_muscle_twitch | 1.70631600 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.70033495 |
| 50 | MP0003959_abnormal_lean_body | 1.68832754 |
| 51 | MP0002272_abnormal_nervous_system | 1.68095979 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.66730946 |
| 53 | MP0005365_abnormal_bile_salt | 1.66107540 |
| 54 | MP0004043_abnormal_pH_regulation | 1.64300422 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 1.63876597 |
| 56 | MP0005253_abnormal_eye_physiology | 1.63693833 |
| 57 | MP0001485_abnormal_pinna_reflex | 1.60634999 |
| 58 | MP0003646_muscle_fatigue | 1.59948342 |
| 59 | MP0005310_abnormal_salivary_gland | 1.59871876 |
| 60 | MP0001756_abnormal_urination | 1.58963009 |
| 61 | MP0001486_abnormal_startle_reflex | 1.54965695 |
| 62 | MP0003436_decreased_susceptibility_to | 1.54226972 |
| 63 | MP0000427_abnormal_hair_cycle | 1.50654704 |
| 64 | MP0002736_abnormal_nociception_after | 1.50091726 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.48380594 |
| 66 | MP0000613_abnormal_salivary_gland | 1.47771799 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.46138689 |
| 68 | MP0000372_irregular_coat_pigmentation | 1.46116577 |
| 69 | MP0005671_abnormal_response_to | 1.43768169 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.42142442 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.41559025 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 1.41478384 |
| 73 | MP0009840_abnormal_foam_cell | 1.38751994 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.36397310 |
| 75 | MP0002166_altered_tumor_susceptibility | 1.35302168 |
| 76 | MP0004142_abnormal_muscle_tone | 1.35089433 |
| 77 | MP0002735_abnormal_chemical_nociception | 1.34539240 |
| 78 | MP0001970_abnormal_pain_threshold | 1.33683885 |
| 79 | MP0002064_seizures | 1.30933830 |
| 80 | MP0008961_abnormal_basal_metabolism | 1.29101040 |
| 81 | MP0009643_abnormal_urine_homeostasis | 1.28133577 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 1.28009539 |
| 83 | MP0002971_abnormal_brown_adipose | 1.27117943 |
| 84 | MP0005025_abnormal_response_to | 1.25670784 |
| 85 | MP0004510_myositis | 1.23355583 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 1.21496286 |
| 87 | MP0002572_abnormal_emotion/affect_behav | 1.20141218 |
| 88 | MP0001765_abnormal_ion_homeostasis | 1.19872224 |
| 89 | MP0003880_abnormal_central_pattern | 1.18921216 |
| 90 | MP0002638_abnormal_pupillary_reflex | 1.17018661 |
| 91 | MP0006276_abnormal_autonomic_nervous | 1.16664985 |
| 92 | MP0005410_abnormal_fertilization | 1.16639977 |
| 93 | MP0005408_hypopigmentation | 1.16373069 |
| 94 | MP0004215_abnormal_myocardial_fiber | 1.15889071 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 1.15669587 |
| 96 | MP0002928_abnormal_bile_duct | 1.15422603 |
| 97 | MP0006054_spinal_hemorrhage | 1.15313136 |
| 98 | MP0001905_abnormal_dopamine_level | 1.15038449 |
| 99 | MP0006292_abnormal_olfactory_placode | 1.14883735 |
| 100 | MP0002419_abnormal_innate_immunity | 1.14598364 |
| 101 | MP0002557_abnormal_social/conspecific_i | 1.14018580 |
| 102 | MP0003122_maternal_imprinting | 1.13716709 |
| 103 | MP0003137_abnormal_impulse_conducting | 1.13677867 |
| 104 | MP0005386_behavior/neurological_phenoty | 1.12761383 |
| 105 | MP0004924_abnormal_behavior | 1.12761383 |
| 106 | MP0004133_heterotaxia | 1.12478253 |
| 107 | MP0004130_abnormal_muscle_cell | 1.12019738 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 1.11978904 |
| 109 | MP0005083_abnormal_biliary_tract | 1.11724078 |
| 110 | MP0005670_abnormal_white_adipose | 1.07113621 |
| 111 | MP0004742_abnormal_vestibular_system | 1.05898725 |
| 112 | MP0005389_reproductive_system_phenotype | 1.05534519 |
| 113 | MP0002229_neurodegeneration | 1.03127111 |
| 114 | MP0002160_abnormal_reproductive_system | 1.02177775 |
| 115 | MP0002723_abnormal_immune_serum | 1.01619770 |
| 116 | MP0001346_abnormal_lacrimal_gland | 1.00756310 |
| 117 | MP0003136_yellow_coat_color | 1.00599436 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.99704811 |
| 119 | MP0000383_abnormal_hair_follicle | 0.99488809 |
| 120 | MP0005448_abnormal_energy_balance | 0.99465350 |
| 121 | MP0002452_abnormal_antigen_presenting | 0.99419993 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.99387309 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.99091079 |
| 124 | MP0005334_abnormal_fat_pad | 0.98067703 |
| 125 | MP0002067_abnormal_sensory_capabilities | 0.96963141 |
| 126 | MP0003635_abnormal_synaptic_transmissio | 0.96292508 |
| 127 | MP0008469_abnormal_protein_level | 0.95997137 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.95544487 |
| 129 | MP0002006_tumorigenesis | 0.95368492 |
| 130 | MP0001984_abnormal_olfaction | 0.94868431 |
| 131 | MP0003121_genomic_imprinting | 0.93608122 |
| 132 | MP0010329_abnormal_lipoprotein_level | 0.92854071 |
| 133 | MP0003953_abnormal_hormone_level | 0.92687214 |
| 134 | MP0003300_gastrointestinal_ulcer | 0.91371579 |
| 135 | MP0002734_abnormal_mechanical_nocicepti | 0.90469763 |
| 136 | MP0006082_CNS_inflammation | 0.90337987 |
| 137 | MP0006072_abnormal_retinal_apoptosis | 0.89794562 |
| 138 | MP0001324_abnormal_eye_pigmentation | 0.89672991 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.89125526 |
| 140 | MP0001533_abnormal_skeleton_physiology | 0.88784642 |
| 141 | MP0001764_abnormal_homeostasis | 0.88359187 |
| 142 | MP0001919_abnormal_reproductive_system | 0.88312829 |
| 143 | MP0001819_abnormal_immune_cell | 0.87332326 |
| 144 | MP0005666_abnormal_adipose_tissue | 0.86600574 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.85843291 |
| 146 | MP0002063_abnormal_learning/memory/cond | 0.85695618 |
| 147 | MP0003172_abnormal_lysosome_physiology | 0.84949746 |
| 148 | MP0001853_heart_inflammation | 0.84373217 |
| 149 | MP0002277_abnormal_respiratory_mucosa | 0.83759440 |
| 150 | MP0001986_abnormal_taste_sensitivity | 0.83676075 |
| 151 | MP0009780_abnormal_chondrocyte_physiolo | 0.83273809 |
| 152 | MP0005535_abnormal_body_temperature | 0.83258856 |
| 153 | MP0005195_abnormal_posterior_eye | 0.82668600 |
| 154 | MP0005085_abnormal_gallbladder_physiolo | 0.82423366 |
| 155 | MP0005647_abnormal_sex_gland | 0.81958618 |
| 156 | MP0000026_abnormal_inner_ear | 0.80823066 |
| 157 | MP0002420_abnormal_adaptive_immunity | 0.80566696 |
| 158 | MP0003866_abnormal_defecation | 0.79478757 |
| 159 | MP0005076_abnormal_cell_differentiation | 0.79411590 |
| 160 | MP0002090_abnormal_vision | 0.77764040 |
| 161 | MP0010678_abnormal_skin_adnexa | 0.77282454 |
| 162 | MP0003252_abnormal_bile_duct | 0.74701437 |
| 163 | MP0000609_abnormal_liver_physiology | 0.73051034 |
| 164 | MP0003045_fibrosis | 0.72961811 |
| 165 | MP0002938_white_spotting | 0.72735687 |
| 166 | MP0001800_abnormal_humoral_immune | 0.71604382 |
| 167 | MP0002136_abnormal_kidney_physiology | 0.71165733 |
| 168 | MP0010155_abnormal_intestine_physiology | 0.68367840 |
| 169 | MP0004947_skin_inflammation | 0.67565703 |
| 170 | MP0005332_abnormal_amino_acid | 0.66820183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 6.64415316 |
| 2 | Hypoglycemic seizures (HP:0002173) | 6.52929460 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.35023600 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.53412206 |
| 5 | Symptomatic seizures (HP:0011145) | 5.49971799 |
| 6 | Hyperglycemia (HP:0003074) | 4.71969155 |
| 7 | Retinal atrophy (HP:0001105) | 4.62042496 |
| 8 | Congenital stationary night blindness (HP:0007642) | 4.23449799 |
| 9 | Late onset (HP:0003584) | 4.23342013 |
| 10 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.19876370 |
| 11 | Ketoacidosis (HP:0001993) | 3.89970023 |
| 12 | Pancreatic cysts (HP:0001737) | 3.88173310 |
| 13 | Increased IgM level (HP:0003496) | 3.67836972 |
| 14 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.56230081 |
| 15 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.56055996 |
| 16 | Nephronophthisis (HP:0000090) | 3.55531933 |
| 17 | Hyperparathyroidism (HP:0000843) | 3.52769534 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.50554072 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.50554072 |
| 20 | Pancreatic fibrosis (HP:0100732) | 3.46387103 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.46267896 |
| 22 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.39765535 |
| 23 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.39765535 |
| 24 | Pendular nystagmus (HP:0012043) | 3.27084904 |
| 25 | True hermaphroditism (HP:0010459) | 3.23895681 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.21423727 |
| 27 | Abnormality of the renal medulla (HP:0100957) | 3.06058760 |
| 28 | Hypercortisolism (HP:0001578) | 3.05682745 |
| 29 | Abnormality of the renal cortex (HP:0011035) | 3.02305816 |
| 30 | Hyperventilation (HP:0002883) | 3.00597758 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.99223965 |
| 32 | Type II lissencephaly (HP:0007260) | 2.98376780 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 2.94991482 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 2.94323689 |
| 35 | Abolished electroretinogram (ERG) (HP:0000550) | 2.90150675 |
| 36 | Large for gestational age (HP:0001520) | 2.88752357 |
| 37 | Growth hormone excess (HP:0000845) | 2.86235358 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.84592028 |
| 39 | Polydipsia (HP:0001959) | 2.81387950 |
| 40 | Abnormal drinking behavior (HP:0030082) | 2.81387950 |
| 41 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.78833184 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.76061007 |
| 43 | Progressive cerebellar ataxia (HP:0002073) | 2.74841939 |
| 44 | Hyperphosphatemia (HP:0002905) | 2.72538978 |
| 45 | Gout (HP:0001997) | 2.72519854 |
| 46 | Prominent metopic ridge (HP:0005487) | 2.71468640 |
| 47 | Menstrual irregularities (HP:0000858) | 2.70807194 |
| 48 | Gaze-evoked nystagmus (HP:0000640) | 2.70784934 |
| 49 | Inability to walk (HP:0002540) | 2.66852182 |
| 50 | Hypomagnesemia (HP:0002917) | 2.66830578 |
| 51 | Insulin resistance (HP:0000855) | 2.65716942 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.64957760 |
| 53 | Congenital sensorineural hearing impairment (HP:0008527) | 2.64503553 |
| 54 | Hyperkalemia (HP:0002153) | 2.64452020 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59002845 |
| 56 | Abnormality of chloride homeostasis (HP:0011422) | 2.53589968 |
| 57 | Hypothermia (HP:0002045) | 2.50112298 |
| 58 | Tubular atrophy (HP:0000092) | 2.49972223 |
| 59 | Basal ganglia calcification (HP:0002135) | 2.49825208 |
| 60 | Tinnitus (HP:0000360) | 2.48184793 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.47684135 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47684135 |
| 63 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.47291790 |
| 64 | Ketosis (HP:0001946) | 2.45679405 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.43731834 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.42684882 |
| 67 | Genetic anticipation (HP:0003743) | 2.42363597 |
| 68 | Neuroendocrine neoplasm (HP:0100634) | 2.41302567 |
| 69 | Abnormality of macular pigmentation (HP:0008002) | 2.40758502 |
| 70 | Dysautonomia (HP:0002459) | 2.40236356 |
| 71 | Osteomalacia (HP:0002749) | 2.39300542 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.39028607 |
| 73 | Increased corneal curvature (HP:0100692) | 2.37806329 |
| 74 | Keratoconus (HP:0000563) | 2.37806329 |
| 75 | Cystic liver disease (HP:0006706) | 2.36282086 |
| 76 | Progressive inability to walk (HP:0002505) | 2.35070940 |
| 77 | Decreased central vision (HP:0007663) | 2.33644133 |
| 78 | Chronic otitis media (HP:0000389) | 2.33332814 |
| 79 | Pheochromocytoma (HP:0002666) | 2.30855079 |
| 80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.29128190 |
| 81 | Agitation (HP:0000713) | 2.25255372 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.24052427 |
| 83 | Polyuria (HP:0000103) | 2.21707700 |
| 84 | Methylmalonic acidemia (HP:0002912) | 2.19400599 |
| 85 | Chronic hepatic failure (HP:0100626) | 2.18735835 |
| 86 | Chorioretinal atrophy (HP:0000533) | 2.18647847 |
| 87 | Adrenal overactivity (HP:0002717) | 2.17994761 |
| 88 | Renal cortical cysts (HP:0000803) | 2.17041394 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.16865204 |
| 90 | Abnormality of renin-angiotensin system (HP:0000847) | 2.15173681 |
| 91 | Birth length less than 3rd percentile (HP:0003561) | 2.14950540 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14719000 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14719000 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14719000 |
| 95 | Abnormality of the metopic suture (HP:0005556) | 2.14079896 |
| 96 | Dialeptic seizures (HP:0011146) | 2.12415442 |
| 97 | Tetraparesis (HP:0002273) | 2.12374366 |
| 98 | Pathologic fracture (HP:0002756) | 2.12069354 |
| 99 | Broad-based gait (HP:0002136) | 2.11515778 |
| 100 | Gingivitis (HP:0000230) | 2.11444965 |
| 101 | Abnormal pancreas size (HP:0012094) | 2.10563576 |
| 102 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.09814401 |
| 103 | Abnormality of alanine metabolism (HP:0010916) | 2.09814401 |
| 104 | Hyperalaninemia (HP:0003348) | 2.09814401 |
| 105 | Exocrine pancreatic insufficiency (HP:0001738) | 2.09326087 |
| 106 | Hemiparesis (HP:0001269) | 2.09063394 |
| 107 | Periodontitis (HP:0000704) | 2.06915751 |
| 108 | Joint swelling (HP:0001386) | 2.05045533 |
| 109 | Hydroxyprolinuria (HP:0003080) | 2.04962826 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 2.04962826 |
| 111 | Nasal polyposis (HP:0100582) | 2.04934637 |
| 112 | Hypergammaglobulinemia (HP:0010702) | 2.04673981 |
| 113 | Abnormality of potassium homeostasis (HP:0011042) | 2.03935572 |
| 114 | Focal seizures (HP:0007359) | 2.03823772 |
| 115 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.03198906 |
| 116 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.03198906 |
| 117 | Hypotension (HP:0002615) | 2.02444591 |
| 118 | Absent speech (HP:0001344) | 2.01987929 |
| 119 | Fair hair (HP:0002286) | 2.01581481 |
| 120 | Tachypnea (HP:0002789) | 2.01440076 |
| 121 | Severe visual impairment (HP:0001141) | 2.01048715 |
| 122 | Hypokalemia (HP:0002900) | 2.00675051 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.99713270 |
| 124 | Gait imbalance (HP:0002141) | 1.98378351 |
| 125 | Abdominal distention (HP:0003270) | 1.98209483 |
| 126 | Conjugated hyperbilirubinemia (HP:0002908) | 1.98070508 |
| 127 | Disproportionate short-trunk short stature (HP:0003521) | 1.97868338 |
| 128 | Hyperactive renin-angiotensin system (HP:0000841) | 1.97788828 |
| 129 | Mitochondrial inheritance (HP:0001427) | 1.97320931 |
| 130 | Hepatic necrosis (HP:0002605) | 1.96608758 |
| 131 | Increased CSF lactate (HP:0002490) | 1.96500976 |
| 132 | Congenital hepatic fibrosis (HP:0002612) | 1.96190526 |
| 133 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95951114 |
| 134 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95951114 |
| 135 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95951114 |
| 136 | Orthostatic hypotension (HP:0001278) | 1.95832268 |
| 137 | Polygenic inheritance (HP:0010982) | 1.95457001 |
| 138 | Protruding tongue (HP:0010808) | 1.95454131 |
| 139 | Abnormality of magnesium homeostasis (HP:0004921) | 1.94968505 |
| 140 | Hypophosphatemia (HP:0002148) | 1.94890533 |
| 141 | Focal motor seizures (HP:0011153) | 1.93445406 |
| 142 | Sclerocornea (HP:0000647) | 1.93202181 |
| 143 | Abnormal biliary tract physiology (HP:0012439) | 1.92954261 |
| 144 | Bile duct proliferation (HP:0001408) | 1.92954261 |
| 145 | Congenital primary aphakia (HP:0007707) | 1.91977276 |
| 146 | Lissencephaly (HP:0001339) | 1.91952243 |
| 147 | Progressive macrocephaly (HP:0004481) | 1.91800850 |
| 148 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91764727 |
| 149 | Furrowed tongue (HP:0000221) | 1.90200783 |
| 150 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87524243 |
| 151 | Febrile seizures (HP:0002373) | 1.87263072 |
| 152 | Absent/shortened dynein arms (HP:0200106) | 1.87042869 |
| 153 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87042869 |
| 154 | Decreased circulating renin level (HP:0003351) | 1.86498576 |
| 155 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.86240142 |
| 156 | Progressive visual loss (HP:0000529) | 1.86192521 |
| 157 | Clumsiness (HP:0002312) | 1.85108575 |
| 158 | Neoplasm of the adrenal cortex (HP:0100641) | 1.84970850 |
| 159 | Increased CSF protein (HP:0002922) | 1.84918201 |
| 160 | Cerebral hemorrhage (HP:0001342) | 1.84877174 |
| 161 | Pigmentary retinal degeneration (HP:0001146) | 1.83290428 |
| 162 | Acute necrotizing encephalopathy (HP:0006965) | 1.83235442 |
| 163 | Oligomenorrhea (HP:0000876) | 1.82662846 |
| 164 | Chronic bronchitis (HP:0004469) | 1.82546548 |
| 165 | Progressive neurologic deterioration (HP:0002344) | 1.82534443 |
| 166 | Stomach cancer (HP:0012126) | 1.81306192 |
| 167 | Congenital, generalized hypertrichosis (HP:0004540) | 1.80917352 |
| 168 | Cardiomegaly (HP:0001640) | 1.80659372 |
| 169 | Abnormality of purine metabolism (HP:0004352) | 1.79793652 |
| 170 | Optic disc pallor (HP:0000543) | 1.79171078 |
| 171 | Abnormal urine output (HP:0012590) | 1.79062635 |
| 172 | Unilateral renal agenesis (HP:0000122) | 1.78396164 |
| 173 | Intestinal atresia (HP:0011100) | 1.78229477 |
| 174 | Hand muscle atrophy (HP:0009130) | 1.78083095 |
| 175 | Chronic sinusitis (HP:0011109) | 1.77056504 |
| 176 | Abnormality of the fovea (HP:0000493) | 1.77004085 |
| 177 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76302088 |
| 178 | Methylmalonic aciduria (HP:0012120) | 1.76105253 |
| 179 | Retinitis pigmentosa (HP:0000510) | 1.76088274 |
| 180 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.75822202 |
| 181 | Pachygyria (HP:0001302) | 1.75806041 |
| 182 | Abnormal ciliary motility (HP:0012262) | 1.75712813 |
| 183 | Metabolic alkalosis (HP:0200114) | 1.74796670 |
| 184 | Recurrent bacterial skin infections (HP:0005406) | 1.74440386 |
| 185 | Constricted visual fields (HP:0001133) | 1.73426447 |
| 186 | Hepatocellular necrosis (HP:0001404) | 1.73278958 |
| 187 | Polycythemia (HP:0001901) | 1.73277023 |
| 188 | Vasculitis (HP:0002633) | 1.73175713 |
| 189 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.72981905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 6.77020439 |
| 2 | WNK3 | 6.19997627 |
| 3 | PIK3CG | 3.55128410 |
| 4 | ACVR1B | 3.54798539 |
| 5 | WNK4 | 3.07043680 |
| 6 | INSRR | 2.82849358 |
| 7 | MAP4K2 | 2.79742265 |
| 8 | MAP3K14 | 2.74245099 |
| 9 | CASK | 2.67069471 |
| 10 | EPHA3 | 2.32448402 |
| 11 | FRK | 2.31570394 |
| 12 | MAP3K2 | 2.22480412 |
| 13 | OXSR1 | 2.21078246 |
| 14 | PINK1 | 2.20976235 |
| 15 | BLK | 2.15195056 |
| 16 | ZAK | 2.01610472 |
| 17 | ERN1 | 1.91759033 |
| 18 | EPHA2 | 1.83892220 |
| 19 | PIM2 | 1.72707954 |
| 20 | CDK19 | 1.72357783 |
| 21 | MAP3K4 | 1.70574401 |
| 22 | TYK2 | 1.62061982 |
| 23 | PASK | 1.61908150 |
| 24 | ARAF | 1.59524393 |
| 25 | TXK | 1.59278466 |
| 26 | STK38L | 1.57786884 |
| 27 | MAPK13 | 1.55094458 |
| 28 | EPHB1 | 1.51491690 |
| 29 | FGFR4 | 1.49225377 |
| 30 | MAP3K13 | 1.48794687 |
| 31 | TRIM28 | 1.46545449 |
| 32 | DYRK1B | 1.45763859 |
| 33 | TESK1 | 1.45588542 |
| 34 | TNIK | 1.39672572 |
| 35 | TAOK3 | 1.38223918 |
| 36 | TBK1 | 1.35034051 |
| 37 | HIPK2 | 1.29748527 |
| 38 | FGFR2 | 1.29669120 |
| 39 | STK39 | 1.29354387 |
| 40 | JAK3 | 1.27067226 |
| 41 | CHUK | 1.24877219 |
| 42 | JAK1 | 1.24033028 |
| 43 | NTRK3 | 1.23763154 |
| 44 | IKBKB | 1.23245282 |
| 45 | TGFBR1 | 1.23010859 |
| 46 | BMPR2 | 1.20615074 |
| 47 | ADRBK1 | 1.20547088 |
| 48 | NEK9 | 1.18658992 |
| 49 | BCR | 1.18443899 |
| 50 | FLT3 | 1.18126677 |
| 51 | PTK6 | 1.12077333 |
| 52 | MKNK2 | 1.09618406 |
| 53 | ERBB3 | 1.07965866 |
| 54 | FER | 1.06038584 |
| 55 | MST1R | 1.04888059 |
| 56 | WNK1 | 1.03418508 |
| 57 | CSK | 1.01462359 |
| 58 | MAP2K2 | 1.00110615 |
| 59 | UHMK1 | 0.99887041 |
| 60 | MAP2K6 | 0.97577729 |
| 61 | BMPR1B | 0.97124279 |
| 62 | IRAK1 | 0.96747786 |
| 63 | KSR2 | 0.96334166 |
| 64 | PHKG2 | 0.96081996 |
| 65 | PHKG1 | 0.96081996 |
| 66 | PIK3CA | 0.95900590 |
| 67 | TLK1 | 0.95482838 |
| 68 | PRKCG | 0.95362604 |
| 69 | SIK1 | 0.94270989 |
| 70 | ZAP70 | 0.93320193 |
| 71 | MAP2K7 | 0.92086613 |
| 72 | MAP3K1 | 0.90884742 |
| 73 | PTK2 | 0.88128858 |
| 74 | MARK1 | 0.87793941 |
| 75 | CSNK1G1 | 0.86179680 |
| 76 | LMTK2 | 0.84463160 |
| 77 | IKBKE | 0.83886891 |
| 78 | PLK2 | 0.82104513 |
| 79 | CSNK1G2 | 0.81033176 |
| 80 | IRAK3 | 0.80790025 |
| 81 | PAK3 | 0.77651684 |
| 82 | TRIB3 | 0.75460370 |
| 83 | CSNK1G3 | 0.75348180 |
| 84 | MST4 | 0.74876240 |
| 85 | STK3 | 0.73009890 |
| 86 | ADRBK2 | 0.72985187 |
| 87 | JAK2 | 0.72195099 |
| 88 | NUAK1 | 0.72172008 |
| 89 | DYRK2 | 0.71068743 |
| 90 | NLK | 0.70278602 |
| 91 | PTK2B | 0.69530571 |
| 92 | MAP3K3 | 0.68541993 |
| 93 | GRK7 | 0.67238317 |
| 94 | IRAK4 | 0.66094900 |
| 95 | NTRK2 | 0.65681595 |
| 96 | PRKAA2 | 0.64759613 |
| 97 | TIE1 | 0.64417629 |
| 98 | PRKCQ | 0.63992637 |
| 99 | TNK2 | 0.63191879 |
| 100 | BRAF | 0.62136594 |
| 101 | MAP3K12 | 0.59992320 |
| 102 | CAMK2A | 0.59489441 |
| 103 | BCKDK | 0.59417764 |
| 104 | PNCK | 0.59209372 |
| 105 | STK11 | 0.59193000 |
| 106 | RIPK4 | 0.58215750 |
| 107 | FGFR3 | 0.58068989 |
| 108 | TEC | 0.56818347 |
| 109 | MAP2K1 | 0.56036661 |
| 110 | BRSK2 | 0.55958264 |
| 111 | VRK1 | 0.55601923 |
| 112 | CSNK1A1L | 0.55527310 |
| 113 | NME1 | 0.55514132 |
| 114 | NTRK1 | 0.50955456 |
| 115 | CSNK1A1 | 0.50788186 |
| 116 | PRKACA | 0.50095958 |
| 117 | ABL2 | 0.49242959 |
| 118 | CAMKK2 | 0.48557758 |
| 119 | MAPKAPK2 | 0.47734927 |
| 120 | PRKCI | 0.46328257 |
| 121 | RIPK1 | 0.45638690 |
| 122 | PRKG1 | 0.44230840 |
| 123 | ITK | 0.43441764 |
| 124 | MAP4K1 | 0.43279126 |
| 125 | PRKCA | 0.42192177 |
| 126 | CAMK1 | 0.42121368 |
| 127 | LRRK2 | 0.42078263 |
| 128 | PRKCE | 0.41415498 |
| 129 | DAPK2 | 0.41274174 |
| 130 | BTK | 0.41101722 |
| 131 | PBK | 0.41034701 |
| 132 | SCYL2 | 0.40584921 |
| 133 | MKNK1 | 0.40397903 |
| 134 | PLK3 | 0.39744523 |
| 135 | LIMK1 | 0.39700818 |
| 136 | PRKAA1 | 0.38384456 |
| 137 | RET | 0.37818786 |
| 138 | CAMK2D | 0.37044218 |
| 139 | GRK5 | 0.36797314 |
| 140 | CAMK1D | 0.36393246 |
| 141 | DAPK3 | 0.36242968 |
| 142 | PRKCZ | 0.35496411 |
| 143 | RPS6KA5 | 0.35412733 |
| 144 | MET | 0.35041468 |
| 145 | EIF2AK3 | 0.34555959 |
| 146 | EIF2AK2 | 0.34495731 |
| 147 | EPHA4 | 0.34471187 |
| 148 | MAPKAPK5 | 0.33267325 |
| 149 | STK16 | 0.32672281 |
| 150 | MAP3K7 | 0.32349177 |
| 151 | GRK1 | 0.31336100 |
| 152 | CDC42BPA | 0.30198814 |
| 153 | MUSK | 0.29488382 |
| 154 | PRKG2 | 0.29427324 |
| 155 | IGF1R | 0.29225399 |
| 156 | MAPKAPK3 | 0.29141527 |
| 157 | SYK | 0.28543027 |
| 158 | LYN | 0.28405929 |
| 159 | RPS6KA1 | 0.27276666 |
| 160 | SIK3 | 0.26796998 |
| 161 | DAPK1 | 0.26741124 |
| 162 | KIT | 0.26363225 |
| 163 | MOS | 0.26091556 |
| 164 | CSNK1D | 0.25997229 |
| 165 | TRPM7 | 0.25546093 |
| 166 | GSK3A | 0.23984152 |
| 167 | EPHB2 | 0.23632667 |
| 168 | ABL1 | 0.22034568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.24310372 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.04312176 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.43026381 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.96707989 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.67439778 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.63112021 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.58165851 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.49228680 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.47266280 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.15409675 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.08420782 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01917817 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.98366019 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.88594871 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81233353 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80035746 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.79068126 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.78929294 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.78427950 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.77268531 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.76970216 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.75346037 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.74075226 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67226991 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.62753172 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.58382202 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.55351836 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53908544 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51805012 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49337710 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46224741 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41923437 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41009600 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.40473759 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.34091784 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32450164 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.28926040 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.27390817 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26381801 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22910015 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22340511 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17824937 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16787489 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15239494 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.14321620 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14098326 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12484397 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.10557913 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 1.10461269 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 1.09703155 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08805541 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.06195951 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05846017 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04780063 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 1.01945140 |
| 56 | Leishmaniasis_Homo sapiens_hsa05140 | 1.01931545 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99083196 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98995776 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98693092 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.98571427 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98409918 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97847272 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.97016362 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95557883 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.94463864 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92634051 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.92586837 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.90740392 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90330022 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88860818 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.88624152 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88302279 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.87628690 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86777445 |
| 75 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86570317 |
| 76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85986936 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85436712 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84471048 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.83883064 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83663305 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83630456 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82933562 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81590694 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81138528 |
| 85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.80385015 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79982038 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.79652269 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.78808326 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78137079 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.77062258 |
| 91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.74182551 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72957191 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.72827900 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69946934 |
| 95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69481525 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69468354 |
| 97 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69358005 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69175798 |
| 99 | Tuberculosis_Homo sapiens_hsa05152 | 0.68913895 |
| 100 | Asthma_Homo sapiens_hsa05310 | 0.68534174 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67983345 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67511890 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66320622 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65513599 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64810870 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63168307 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62628268 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.61228218 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60734951 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.60529742 |
| 111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59309984 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59129479 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57836059 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57513116 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55192845 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54093164 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51890238 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50867439 |
| 119 | RNA degradation_Homo sapiens_hsa03018 | 0.50461506 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50119431 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50094645 |
| 122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49981071 |
| 123 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.48921993 |
| 124 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46727148 |
| 125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45520280 |
| 126 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.45446417 |
| 127 | Malaria_Homo sapiens_hsa05144 | 0.44160090 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43491517 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43349357 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43241237 |
| 131 | Purine metabolism_Homo sapiens_hsa00230 | 0.43076897 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42805256 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.42613352 |
| 134 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42068661 |
| 135 | Renin secretion_Homo sapiens_hsa04924 | 0.41999431 |
| 136 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41279380 |
| 137 | Long-term depression_Homo sapiens_hsa04730 | 0.41063979 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40697369 |
| 139 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40317634 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40089588 |
| 141 | Salmonella infection_Homo sapiens_hsa05132 | 0.39920528 |
| 142 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39700053 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38809604 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.38666802 |
| 145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38293770 |
| 146 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37673901 |
| 147 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33743207 |
| 148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32479602 |
| 149 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32141480 |
| 150 | Bladder cancer_Homo sapiens_hsa05219 | 0.31607918 |
| 151 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31346071 |
| 152 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30416459 |
| 153 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29454866 |
| 154 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29344209 |
| 155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28680868 |
| 156 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28597990 |
| 157 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27570965 |
| 158 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26987683 |
| 159 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26789972 |
| 160 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26254061 |
| 161 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25438545 |
| 162 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24695843 |
| 163 | Hepatitis B_Homo sapiens_hsa05161 | 0.24488147 |
| 164 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23247086 |

